FIERCELY
FOCUSED

on the development of novel
treatments for patients with
B-cell malignancies and
autoimmune diseases.

Learn
about us

Explore our
pipeline

investor
Information

Read our
publications

Latest News

TG Therapeutics to Present at the Jefferies 2020 Healthcare Conference

Presentation scheduled for tomorrow, Wednesday, June 3, 2020, at 10:00 AM ET NEW YORK , June 02, 2020 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced that Michael S. Weiss , the Company’s Executive Chairman and Chief Executive Officer, will participate in a fireside chat

Read More >

2 Gansevoort Street, 9th Floor
New York, NY 10014

Email Us (212) 554-4484